Subthreshold α2-Adrenergic Activation Counteracts Glucagon-Like Peptide-1 Potentiation of Glucose-Stimulated Insulin Secretion
2011

How Clonidine Affects Insulin Secretion

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): Minglin Pan, Yang Guang, Cui Xiuli, Yang Shao-Nian

Primary Institution: Tianjin Medical University

Hypothesis

Does subthreshold α2-adrenergic activation interact with GLP-1 to regulate insulin secretion?

Conclusion

Subthreshold α2-adrenergic activation counteracts GLP-1's effect on insulin secretion.

Supporting Evidence

  • Clonidine inhibits insulin secretion in a concentration-dependent manner.
  • GLP-1 potentiates insulin secretion when glucose levels are elevated.
  • Subthreshold clonidine can completely counteract the effects of GLP-1 on insulin secretion.

Takeaway

When the body needs to control insulin release, a small amount of clonidine can stop GLP-1 from helping insulin secretion.

Methodology

INS-1 cells were treated with glucose and either clonidine or GLP-1 to measure insulin secretion.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2011/604989

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication